CLASS I Drug recall · Reported 21 Feb 2018 · FDA Enforcement Report
Senna Laxative (sennosides) tablets, 6 mg recalled
Magno Humphries Laboratories is recalling Senna Laxative (sennosides) tablets, 6 mg, distributed nationwide in the US. The recall was initiated on 17 Jan 2018 and the FDA has classified it as Class I.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0342-2018
- FDA event ID
- 78952
- Recalling firm
- Magno Humphries Laboratories, Tigard, OR
- Classification
- Class I
- Status
- Terminated
- Recall initiated
- 17 Jan 2018
- FDA classified
- 9 Feb 2018
- Reported
- 21 Feb 2018
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Packaging Defects
Timeline
| 17 Jan 2018 | Recall initiated by company | |
| 9 Feb 2018 | Classified by FDA | +23 days |
| 21 Feb 2018 | Published in enforcement report | +12 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Labeling: Label Mix-Up: Customer complaint received that a bottle labeled as Senna Laxative contained only tablets of Naproxen Sodium 220 mg.
Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.
Product as listed by the FDA
Senna Laxative (sennosides) tablets, 8.6 mg, 100-count bottles, Manufactured for: Basic Drugs, Inc., Vandalia, Ohio 45377, UPC Code 3 07610 22020 1.
Where it was distributed
Nationwide in the USA
Questions about this recall
Is Senna Laxative (sennosides) tablets, 6 mg recalled?
Yes. Magno Humphries Laboratories recalled Senna Laxative (sennosides) tablets, 6 mg on 17 Jan 2018. The recall is Class I and its status is Terminated. Recall number D-0342-2018.
Why was it recalled?
Labeling: Label Mix-Up: Customer complaint received that a bottle labeled as Senna Laxative contained only tablets of Naproxen Sodium 220 mg.
Which lots are affected?
Lot # 352300, Exp 01/19
Where was it sold?
Nationwide in the USA
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class I mean?
Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.
Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from Magno Humphries Laboratories
All 2| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Food | CLASS II | Optimum E-1000 IU Gluten Free Dietary Supplement Product is recalledOptimum E-1000 | Magno Humphries Laboratories | Foreign Material | Nationwide |